LIVIVO - Search results -

Search results

Result 1 - 10 of total 12

Search options

Article ; Online: Top cited publications for treatment of keloid with radiotherapy: A Bibliometric analysis.

Siavashpour, Zahra / Houshyari, Mohammad / Dadkhahfar, Sahar / Jafari, Anya

Journal of cancer research and therapeutics

2023 Volume 19, Issue Suppl 2, Page(s) S472–S476

Abstract: Abstracts: The use of radiation to treat keloid scars has gained popularity during the last few decades. However, few bibliometric analyses have been performed on the published articles. This research aimed to demonstrate and evaluate the trends, top- ... ...

Abstract	Abstracts: The use of radiation to treat keloid scars has gained popularity during the last few decades. However, few bibliometric analyses have been performed on the published articles. This research aimed to demonstrate and evaluate the trends, top-cited articles, and frontier areas. In this cross-sectional study, Web of Science (WOS) and Scopus database literature was searched for all MESH terms related to "keloid" and "radiotherapy." The bibliometric analysis was carried out by VOSviewer 1.6.15. Articles with Web of Science-based citations of ≥20 were included. The citation per year index (CPYI) of articles was calculated for further inclusion of papers if they had CPYI higher than the mean value. There were 95 papers on keloid radiation that satisfied the inclusion criteria and were published between 1942 and 2019. The CPYI ranged from 0.38 to 11.3. Most studies were published in the "International Journal of Radiation Oncology, Biology, and Physics" (9 papers). The United States has the most papers (14), followed by Japan (9), the Netherlands (7), and Germany (5). To the best of our knowledge, this is the first bibliometric analysis of top-cited papers on keloid radiotherapy. From 2014 to the present, it seems that this title has resurfaced as a popular topic, with radiotherapy within 24 h of surgery being the most commonly recommended treatment plan. Since around 2011, high-dose-rate brachytherapy (HDR-BT) has been used as an effective treatment for keloid control. Individualization of therapy and dose/technique based on the location is strongly suggested.
MeSH term(s)	Humans ; United States ; Radiation Oncology ; Cross-Sectional Studies ; Keloid/radiotherapy ; Bibliometrics ; Brachytherapy
Language	English
Publishing date	2023-04-07
Publishing country	India
Document type	Journal Article
ZDB-ID	2187633-2
ISSN	1998-4138 ; 0973-1482
ISSN (online)	1998-4138
ISSN	0973-1482
DOI	10.4103/jcrt.jcrt_1235_22
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma: a case report.

Rakhsha, Afshin / Mahboubi-Fooladi, Zahra / Jafari, Anya

Journal of medical case reports

2021 Volume 15, Issue 1, Page(s) 218

Abstract: Background: The outbreak of coronavirus disease 2019 (COVID-19) started in December 2020, and is a global problem now. There are several sets of established data regarding computed tomography (CT) findings in COVID-19 pneumonia with many differential ... ...

Abstract	Background: The outbreak of coronavirus disease 2019 (COVID-19) started in December 2020, and is a global problem now. There are several sets of established data regarding computed tomography (CT) findings in COVID-19 pneumonia with many differential diagnoses. During the early days of the pandemic, there was little data regarding lung CT features of COVID-19 in a cancer patient. In this paper, we described a rare case of simultaneous presentation of COVID-19 with pulmonary metastasis. Case presentation: A Persian patient with a history of chondrosarcoma presented to our clinic during the COVID-19 pandemic with a new-onset cough. He had experienced no recurrence during previous follow-up visits. Chest CT scan revealed numerous bilateral small peripheral and perilymphatic pulmonary nodules, unilateral ground-glass patch, and nodular interlobular septal thickening. Biopsy of the pulmonary nodules established pulmonary metastasis of chondrosarcoma origin, and pharyngeal reverse transcription polymerase chain reaction (RT-PCR) was positive for COVID-19. Conclusion: Pulmonary metastasis should be considered as a differential diagnosis of COVID-19 features in cancer patients in the pandemic era.
MeSH term(s)	COVID-19/complications ; COVID-19/diagnosis ; COVID-19/epidemiology ; Chondrosarcoma/epidemiology ; Diagnosis, Differential ; Humans ; Iran/epidemiology ; Lung Neoplasms/complications ; Lung Neoplasms/diagnosis ; Male ; Middle Aged
Language	English
Publishing date	2021-04-28
Publishing country	England
Document type	Case Reports
ZDB-ID	2269805-X
ISSN	1752-1947 ; 1752-1947
ISSN (online)	1752-1947
ISSN	1752-1947
DOI	10.1186/s13256-021-02753-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma

Afshin Rakhsha / Zahra Mahboubi-Fooladi / Anya Jafari

Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-

a case report

2021 Volume 3

Abstract: Abstract Background The outbreak of coronavirus disease 2019 (COVID-19) started in December 2020, and is a global problem now. There are several sets of established data regarding computed tomography (CT) findings in COVID-19 pneumonia with many ... ...

Abstract	Abstract Background The outbreak of coronavirus disease 2019 (COVID-19) started in December 2020, and is a global problem now. There are several sets of established data regarding computed tomography (CT) findings in COVID-19 pneumonia with many differential diagnoses. During the early days of the pandemic, there was little data regarding lung CT features of COVID-19 in a cancer patient. In this paper, we described a rare case of simultaneous presentation of COVID-19 with pulmonary metastasis. Case presentation A Persian patient with a history of chondrosarcoma presented to our clinic during the COVID-19 pandemic with a new-onset cough. He had experienced no recurrence during previous follow-up visits. Chest CT scan revealed numerous bilateral small peripheral and perilymphatic pulmonary nodules, unilateral ground-glass patch, and nodular interlobular septal thickening. Biopsy of the pulmonary nodules established pulmonary metastasis of chondrosarcoma origin, and pharyngeal reverse transcription polymerase chain reaction (RT-PCR) was positive for COVID-19. Conclusion Pulmonary metastasis should be considered as a differential diagnosis of COVID-19 features in cancer patients in the pandemic era.
Keywords	Case report ; COVID-19 ; SARS-CoV-2 ; Chondrosarcoma ; Pulmonary metastasis ; Medicine ; R
Subject code	610
Language	English
Publishing date	2021-04-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.

Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

Critical reviews in oncology/hematology

2020 Volume 151, Page(s) 102982

Abstract: SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment ... ...

Abstract	SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
MeSH term(s)	Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Drug Interactions ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
Chemical Substances	Antineoplastic Agents
Keywords	covid19
Language	English
Publishing date	2020-05-12
Publishing country	Netherlands
Document type	Journal Article ; Review
ZDB-ID	605680-5
ISSN	1879-0461 ; 0737-9587 ; 1040-8428
ISSN (online)	1879-0461
ISSN	0737-9587 ; 1040-8428
DOI	10.1016/j.critrevonc.2020.102982
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1931: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Primary Prostate Lymphoma Managed with Combined Modality Treatment: A Case Report.

Jafari, Anya / Mofid, Bahram / Tabibi, Ali / Kowsari, Farid

Urology journal

2019 Volume 16, Issue 4, Page(s) 412–414

Abstract: Prostate cancer is one of the most common malignancies in men; the main reported pathology is adenocarcinoma while there are few published cases of prostate lymphoma. There isn't enough data regarding the natural history and best management of prostate ... ...

Abstract	Prostate cancer is one of the most common malignancies in men; the main reported pathology is adenocarcinoma while there are few published cases of prostate lymphoma. There isn't enough data regarding the natural history and best management of prostate lymphoma. In this paper, we have described a case of prostate lymphoma that managed with combined modality treatment and have been survived for three years.
MeSH term(s)	Aged ; Combined Modality Therapy ; Humans ; Lymphoma, Large B-Cell, Diffuse/therapy ; Male ; Prostatic Neoplasms/therapy
Language	English
Publishing date	2019-08-18
Publishing country	Iran
Document type	Case Reports ; Journal Article
ZDB-ID	2251940-3
ISSN	1735-546X ; 1735-1308
ISSN (online)	1735-546X
ISSN	1735-1308
DOI	10.22037/uj.v0i0.4294
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

Critical Reviews in Oncology/Hematology

2020 Volume 151, Page(s) 102982

Keywords	Oncology ; Geriatrics and Gerontology ; Hematology ; General Medicine ; covid19
Language	English
Publisher	Elsevier BV
Publishing country	us
Document type	Article ; Online
ZDB-ID	605680-5
ISSN	0737-9587 ; 1040-8428
ISSN	0737-9587 ; 1040-8428
DOI	10.1016/j.critrevonc.2020.102982
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Zs.A 1931: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

Crit Rev Oncol Hematol

Abstract	SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #400529
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis.

Mofid, Bahram / Razzaghdoust, Abolfazl / Ghajari, Mahdi / Basiri, Abbas / Fattahi, Mohammad-Reza / Houshyari, Mohammad / Jafari, Anya / Taghizadeh-Hesary, Farzad

Urology journal

2022 Volume 19, Issue 5, Page(s) 371–378

Abstract: Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) is the standard of care in non-metastatic muscle-invasive bladder cancer (MIBC). There are limited data regarding the alternative choices for cisplatin-ineligible patients. This study has ... ...

Abstract	Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) is the standard of care in non-metastatic muscle-invasive bladder cancer (MIBC). There are limited data regarding the alternative choices for cisplatin-ineligible patients. This study has investigated the oncological outcomes of gemcitabine plus cisplatin (Gem/Cis) and gemcitabine plus carboplatin (Gem/Carbo) in this setting. Materials and methods: One hundred forty consecutive patients with MIBC (cT2-T4a) receiving neoadjuvant Gem/Cis or Gem/Carbo before chemoradiation (CRT) or radical cystectomy (RC) were retrospectively evaluated between April 2009 and April 2019. Patients with ECOG performance status 2, creatinine clearance < 60 mL/min, hydronephrosis, ejection fraction < 50%, or single kidney received Gem/Carbo. The complete clinical response (cCR) and overall survival (OS) of NAC regimens were compared. Prognostic significance was assessed with Cox proportional hazards model. Results: In total, 79 patients (56.4%) received Gem/Cis. The cCR was not significantly different between Gem/Cis and Gem/Carbo regimens (38.7% vs. 36.2%, P = .771). After NAC, 79 patients (56.4%) received CRT, and other cases underwent RC. After a median follow-up of 43 months, patients in the Gem/Cis group had significantly better OS than Gem/Carbo (median OS: 41.0 vs. 26.0 months, P = .008). Multivariable Cox proportional hazards models identified cT4a stage (95% confidence interval [95% CI]: 1.001-4.85, hazard ratio [HR] = 2.08, P = .03) and cCR (95% CI: 0.26-0.99, HR = 0.51, P = .04) as the only independent prognostic factors of OS, and ruled out the type of NAC regimen. Conclusion: The choice of NAC (between Gem/Cis and Gem/Carbo) is not the predictor of survival and both regimens had similar cCR.
MeSH term(s)	Humans ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology ; Neoadjuvant Therapy ; Cisplatin ; Retrospective Studies ; Carboplatin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cystectomy
Chemical Substances	Cisplatin (Q20Q21Q62J) ; gemcitabine (B76N6SBZ8R) ; Carboplatin (BG3F62OND5)
Language	English
Publishing date	2022-11-08
Publishing country	Iran
Document type	Journal Article
ZDB-ID	2251940-3
ISSN	1735-546X ; 1735-1308
ISSN (online)	1735-546X
ISSN	1735-1308
DOI	10.22037/uj.v19i.6841
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer.

Razzaghdoust, Abolfazl / Ghajari, Mahdi / Basiri, Abbas / Torbati, Peyman Mohammadi / Jafari, Anya / Fattahi, Mohammad Reza / Salahi, Maryam / Mofid, Bahram

Investigative and clinical urology

2021 Volume 62, Issue 3, Page(s) 274–281

Abstract: Purpose: A readily accessible biomarker to identify which patients with bladder cancer are more likely to respond to neoadjuvant chemotherapy (NAC) could help clinicians avoid unnecessary chemotherapy and prevent its subsequent complications in some ... ...

Abstract	Purpose: A readily accessible biomarker to identify which patients with bladder cancer are more likely to respond to neoadjuvant chemotherapy (NAC) could help clinicians avoid unnecessary chemotherapy and prevent its subsequent complications in some patients. The primary objective of this study was to investigate the association of immunohistochemical markers of tumor subtype with response to NAC and survival of patients with muscle-invasive bladder cancer (MIBC). Materials and methods: MIBC patients treated with NAC were retrospectively included. The tissue microarrays were assembled from transurethral resection of bladder tumor (TURBT) specimens and immunohistochemistry (IHC) was performed. The association of independent variables, including IHC markers, and clinical covariates with clinical complete response to NAC and with overall survival was assessed by using logistic regression and Cox proportional hazard regression analysis, respectively. Kaplan-Meier curves were plotted for different IHC-based tumor subtypes. Results: Data from 140 MIBC patients treated with NAC were retrospectively reviewed. A total of 63 patients with available TURBT specimens were eligible to be included in the analysis. Our results showed that the IHC signature of KRT5/6(+)/KRT20(-), as a combined marker of basal subtype, was the only covariate significantly associated with complete response to NAC (p=0.037). Moreover, we found no statistically significant differences in overall survival between different IHC-based subtypes (p=0.721). Conclusions: The IHC expression of KRT5/6 and KRT20, as a readily accessible combined marker, may help us to identify the patients most likely to benefit from chemotherapy. The clinical utility of this marker needs to be established in larger prospective studies.
MeSH term(s)	Aged ; Antineoplastic Agents/therapeutic use ; Biomarkers/metabolism ; Chemotherapy, Adjuvant ; Cystectomy ; Female ; Humans ; Immunohistochemistry ; Keratin-20/metabolism ; Keratin-5/metabolism ; Keratin-6/metabolism ; Logistic Models ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Invasiveness ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; Urinary Bladder Neoplasms/metabolism ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/therapy
Chemical Substances	Antineoplastic Agents ; Biomarkers ; KRT20 protein, human ; KRT5 protein, human ; KRT6A protein, human ; Keratin-20 ; Keratin-5 ; Keratin-6
Language	English
Publishing date	2021-05-04
Publishing country	Korea (South)
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2923014-7
ISSN	2466-054X ; 2466-0493
ISSN (online)	2466-054X
ISSN	2466-0493
DOI	10.4111/icu.20200425
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Incidence of Seminoma Cancer in Staffs that Worked in Electromagnetic Waves Station; Three Cases Report.

Houshyari, Mohammad / Jafari, Anya / Mostaar, Ahmad

Iranian journal of cancer prevention

2015 Volume 8, Issue 1, Page(s) 66–68

Abstract: Physical agents such as ultraviolet or ionizing radiation and repetitive trauma have been related to the causation of cancer in humans. Much less clear is the association between exposure to radiofrequency, such as radar and microwave radiation to the ... ...

Abstract	Physical agents such as ultraviolet or ionizing radiation and repetitive trauma have been related to the causation of cancer in humans. Much less clear is the association between exposure to radiofrequency, such as radar and microwave radiation to the development of cancer. Sporadic case reports and small series suggest that this type of radiation might lead to cancer or contribute to its evolution. The association between radiofrequency and testicular damage and cancer is unproved, but clinical and experimental data are suggestive of such possibility. In this paper we have reported three cases of seminoma in person who worked in the same place that exposed to radio frequency (RF) waves.
Language	English
Publishing date	2015-03-25
Publishing country	Iran
Document type	Case Reports
ZDB-ID	2577885-7
ISSN	2008-2401 ; 2008-2398
ISSN (online)	2008-2401
ISSN	2008-2398
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito